Acoziborole for trypanosomiasis

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Also followed for narrower conditions: Trypanosomiasis, African

Why this status

  1. 15 Mar 2024: Trial started, NCT07789743
  2. 27 Aug 2026: Trial registered, NCT07789743

The trials

NCT07789743: Stop Transmission of Gambiense Human African Trypanosomiasis

State
Under way
Phase
Phase 3
People
2,500 planned
Started
15 Mar 2024
Primary completion
30 Dec 2026
Arms
treatment of seropositives
Results
None posted
  1. 15 Mar 2024: Trial started
  2. 27 Aug 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.